Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples

被引:139
|
作者
Rassen, Jeremy A. [1 ,2 ]
Glynn, Robert J. [1 ,2 ]
Brookhart, M. Alan [3 ]
Schneeweiss, Sebastian [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
基金
美国医疗保健研究与质量局;
关键词
algorithms; comparative effectiveness research; computing methodologies; confounding factors (epidemiology); epidemiologic methods; pharmacoepidemiology; propensity score; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOGISTIC-REGRESSION ANALYSIS; UNMEASURED CONFOUNDERS; SENSITIVITY-ANALYSIS; COMPARATIVE SAFETY; CLAIMS DATA; GASTROINTESTINAL TOXICITY; EPIDEMIOLOGIC RESEARCH; RHEUMATOID-ARTHRITIS; EXTERNAL ADJUSTMENT;
D O I
10.1093/aje/kwr001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To reduce bias by residual confounding in nonrandomized database studies, the high-dimensional propensity score (hd-PS) algorithm selects and adjusts for previously unmeasured confounders. The authors evaluated whether hd-PS maintains its capabilities in small cohorts that have few exposed patients or few outcome events. In 4 North American pharmacoepidemiologic cohort studies between 1995 and 2005, the authors repeatedly sampled the data to yield increasingly smaller cohorts. They identified potential confounders in each sample and estimated both an hd-PS that included 0-500 covariates and treatment effects adjusted by decile of hd-PS. For sensitivity analyses, they altered the variable selection process to use zero-cell correction and, separately, to use only the variables' exposure association. With >50 exposed patients with an outcome event, hd-PS-adjusted point estimates in the small cohorts were similar to the full-cohort values. With 25-50 exposed events, both sensitivity analyses yielded estimates closer to those obtained in the full data set. Point estimates generally did not change as compared with the full data set when selecting >300 covariates for the hd-PS. In these data, using zero-cell correction or exposure-based covariate selection allowed hd-PS to function robustly with few events. hd-PS is a flexible analytical tool for nonrandomized research across a range of study sizes and event frequencies.
引用
收藏
页码:1404 / 1413
页数:10
相关论文
共 50 条
  • [31] Evaluation of propensity score methods for causal inference with high-dimensional covariates
    Gao, Qian
    Zhang, Yu
    Sun, Hongwei
    Wang, Tong
    BRIEFINGS IN BIOINFORMATICS, 2022, 23 (04)
  • [32] Propensity Score Prediction for Electronic Healthcare Databases Using Super Learner and High-Dimensional Propensity Score Methods
    Ju, Cheng
    Combs, Mary
    Lendle, Samuel D.
    Franklin, Jessica M.
    Wyss, Richard
    Schneeweiss, Sebastian
    van der Laan, Mark
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 421 - 422
  • [33] Performance of the High-dimensional Propensity Score in Adjusting for Hidden Measured Confounders
    Guertin, Jason R.
    Rahme, Elham
    LeLorier, Jacques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 219 - 219
  • [34] Letter in response to Schneeweiss and Rassen on the high-dimensional propensity score approach
    Toh, Sengwee
    Garcia Rodriguez, Luis A.
    Hernan, Miguel A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (10) : 1112 - 1112
  • [35] Bayesian Variable Selection in Structured High-Dimensional Covariate Spaces With Applications in Genomics
    Li, Fan
    Zhang, Nancy R.
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2010, 105 (491) : 1202 - 1214
  • [36] MODEL-ASSISTED INFERENCE FOR COVARIATE-SPECIFIC TREATMENT EFFECTS WITH HIGH-DIMENSIONAL DATA
    Wu, Peng
    Tan, Zhiqiang
    Hu, Wenjie
    Zhou, Xiao-Hua
    STATISTICA SINICA, 2024, 34 (01) : 459 - 479
  • [37] Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score
    Austin, Peter C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (12) : 1202 - 1217
  • [38] Inference on Treatment Effects after Selection among High-Dimensional ControlsaEuro
    Belloni, Alexandre
    Chernozhukov, Victor
    Hansen, Christian
    REVIEW OF ECONOMIC STUDIES, 2014, 81 (02): : 608 - 650
  • [39] Head to Head Comparison of the Propensity Score and High-Dimensional Propensity Score Matching Methods in Reducing Potential Indication Bias
    Guertin, Jason R.
    Rahme, Elham
    Dormuth, Colin R.
    LeLorier, Jacques
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 197 - 197
  • [40] Eye drops for dry eye disease during pregnancy and adverse neonatal outcomes: high-dimensional propensity score analyses
    Hashimoto, Yohei
    Yamana, Hayato
    Michihata, Nobuaki
    Shigemi, Daisuke
    Ishimaru, Miho
    Matsui, Hiroki
    Yasunaga, Hideo
    Aihara, Makoto
    OPHTHALMIC EPIDEMIOLOGY, 2022, 29 (04) : 384 - 393